Diabetes Mellitus Clinical Trial
Official title:
The Effect of Motivational Interviewing on Well-being, Stress and Difficulties in Individuals With Diabetes
This study will be conducted using a randomized controlled trial design to evaluate the effect of online individual motivational interviewing on well-being, stress and difficulties in individuals with diabetes. The study will be conducted between March 2024 and March 2025 with individuals with Type 2 Diabetes who are followed up in Yozgat Bozok University Health Practice and Research Center Internal Medicine Polyclinic. The motivational interview group will receive a motivational interview once a week, lasting a maximum of 40 minutes, consisting of a total of four sessions. Chi-square (X2), t-test, repeated measures analysis of variance, Pearson correlation coefficient, partial eta-square and linear regression analysis will be used to evaluate the data.
Approximately 537 million people worldwide have diabetes and it is estimated to reach 643 million in 2030 and 783 million in 2045. In this context, the prevalence of diabetes is increasing and 1.5 million people die each year due to diabetes. Diabetes is a chronic disease that requires complex care activities and multiple decision-making related to self-management. In particular, the most common is type 2 diabetes in adults, which occurs when the body becomes resistant to insulin or does not produce enough insulin. Daily self-management of the disease is necessary for individuals with type 2 diabetes to achieve healthy glucose levels, minimize the effects of the disease on their daily lives and reduce the risk of developing complications. The main elements of self-management in individuals with diabetes include taking medication, maintaining a healthy diet, regular physical activity, foot care and monitoring blood glucose for insulin users. Managing diabetes is a process that requires continuous effort and adherence to multiple health behaviors, and many patients have difficulty managing this chronic condition. This situation increases stress in individuals and causes deterioration in well-being and psychosocial status. Stress in individuals with diabetes can negatively affect problem-solving skills and lead to poor self-management behavior. However, it has also been reported that positive well-being in individuals with diabetes has a good effect on disease management (better glucose control, reduced disease burden, increased work productivity and reduced mortality). However, individuals with type 2 diabetes have been found to have lower well-being than the general population. Therefore, it is important to develop stress coping strategies and support positive well-being for people with diabetes. The control of diabetes depends on the individual's healthy lifestyle behaviors and disease management as well as the pharmacological treatment option. However, many systematic reviews show that motivational interviewing is an effective intervention method in the treatment of diabetes. These studies have shown that it has positive effects on diet and weight management, diabetes self-management, medication adherence, and glycemic control in individuals with diabetes. Looking at the literature, although less stress and positive well-being are important to overcome the difficulties in disease management in individuals with diabetes, studies on supporting stress and positive well-being in type 2 diabetes patients are limited. In this context, this study will be conducted to determine the effect of motivational interviewing applied to individuals with diabetes on well-being, stress and difficulties. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |